港A兩地光伏股集體上漲 光伏行業前三季淨利802億創新高
格隆匯11月4日丨港A兩地光伏股集體上漲,港股方面,信義光能、福萊特玻璃漲約9%,新特能源、水發興業能源漲超7%;A股方面,TCL中環、天合光能、福斯特、晶澳科技漲超5%,隆基漲超3%。消息面上,國家能源局統計數據顯示,2022年前三季度,我國光伏產業累計裝機規模3.58億千瓦,新增裝機規模0.53億千瓦,同比增長105.83%,裝機規模幾乎接近去年全年的數據。今年前三季度,光伏設備行業A股公司總營收達到6465.7億元,同比增速81%,營收規模創歷史新高,增速創10年來新高;合計淨利潤802億元,同比增長123.62%,盈利總額創歷史新高,增速創7年來新高。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.